Table 4 Comparison between the genotypes of PAI-1 regarding demographic and clinical data in diabetes with vascular complication group

Age (years) (mean ± SD)

48.00 ± 5.76

49.06 ± 6.89

48.43 ± 5.95

0.867^{NS, 1}

Gender [n (%)]

0.933 ^{NS, 2}

Male

6 (75.0)

35 (74.5)

20 (71.4)

Female

2 (25.0)

12 (25.5)

8 (28.6)

Smoking [n (%)]

< 0.001 ^HS,2

No

7 (87.5)

25 (53.2)

27 (96.4)

Yes

1 (12.5) _{a, b}

22 (46.8) _b

1 (3.6) _a

Dyslipidemia [n (%)]

0.096 ^{NS, 2}

Absent

1 (12.5)

0 (0.0)

0 (0.0)

Present

7 (87.5)

47 (100.0)

28 (100.0)

Hypertension [n (%)]

0.385 ^{NS, 2}

Absent

2 (25.0)

5 (10.6)

4 (14.3)

Present

6 (75.0)

42 (89.4)

24 (85.7)

Duration of DM (years)

4.0 (2.9)

3.8 (3.8)

3.60 (2.23)

0.729 ^{NS, 3}

PAI-1

26.5 (6.25)_a

65.0 (10.0)_b

48.5 (11)_c

< 0.001 ^{HS, 3}

TAFI

46.5 (14.5)_a

115.0 (42.0)_b

74 (24)_a

< 0.001 ^{HS, 3}

d-dimer (mg/dl)

0.70 (0.20)_a

2.90 (0.80)_b

1.40 (0.98)_c

< 0.001 ^{HS, 3}

BMI (kg/m³)

27.20 (2.15)_a,b

31.20 (5.40)_a

26.70 (2.65)_b

< 0.001 ^{HS, 3}

SBP (mmHg)

120.0 (32.50)_{a, b}

155.0 (40.0)_a

120 (17.0)_b

0.001 ^{HS, 3}

DBP (mmHg)

80 (20.50)_a,b

94 (26.00)_a

82 (10.0) _b

0.004 ^{HS, 3}

FBS (mg/dl)

122.5 (17.25)_{a, b}

145 (47)_a

121.50 (21.25)_b

0.027 ^{S, 3}

2Hr BS (mg/dl)

146.0 (18.5)

167.0 (55.0)

148.50 (34.75)

0.078 ^{NS, 3}

HbA1c (%)

7.0 (1.30)

8.0 (2.40)

7.20 (0.98)

0.055 ^{NS, 3}

T. C (mg/dl)

187.5 (21.75)_a

198.0 (22.0)_b

197.50 (35.00)_{a, b}

0.024 ^{S, 3}

Triglycerides (mg/dl)

151.5 (12.5)_a

170.0 (35.0)_b

166.0 (29.25)_b

< 0.001 ^{HS, 3}

LDL (mg/dl) (mean ± SD)

116.83 ± 8.55

130.11 ± 18.38

121.93 ± 21.33

0.084 ^{NS, 1}

HDL (mg/dl) (mean ± SD)

36.25 ± 5.18

37.09 ± 5.42

39.57 ± 4.03

0.077 ^{NS, 1}